Updated Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol.
Pawar A, Desai RJ, Liu J, Kim E, Kim SC.
J Am Heart Assoc. 2021 Apr 06. 10(7):e020045. PMID: 33764153
Other Academic
Seoyoung C. Kim
Other Positions
Associate Professor of Medicine
Medicine
Brigham and Women's Hospital
Links
Overview
Seoyoung C. Kim, M.D, Sc.D, M.S.C.E, is an Associate Professor of Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. She is the Director of the Program in Rheumatologic, Immunologic, and Musculoskeletal PharmacoEpidemiology (PRIME).
She is board-certified in Rheumatology, and co-appointed in the Division of Rheumatology, Immunology and Allergy at Brigham and Women’s Hospital. Her research focuses on comparative safety and effectiveness of medications for the rheumatic diseases as well as health services/outcome research in Rheumatology.
Dr. Kim is an Associate Editor for Arthritis Care & Research and ACR Open Rheumatology and has served on a number of Committees for the American College of Rheumatology and the International Society for Pharmacoepidemiology.
Bibliography
Risk of venous thromboembolism associated with tofacitinib in patients with rheumatoid arthritis: a population-based cohort study.
Desai RJ, Pawar A, Khosrow-Khavar F, Weinblatt ME, Kim SC.
Rheumatology (Oxford). 2021 Mar 22. PMID: 33752237
Validation of claims-based algorithms to identify patients with psoriasis.
Lee H, He M, Cho SK, Bessette L, Tong AY, Merola JF, Wegrzyn LR, Kilpatrick RD, Kim SC.
Pharmacoepidemiol Drug Saf. 2021 Mar 13. PMID: 33715280
Trends in Utilization of Urate-Lowering Therapies Following the US Food and Drug Administration's Boxed Warning on Febuxostat.
Kim SC, Neogi T, Kim E, Lii J, Desai RJ.
Arthritis Rheumatol. 2021 03. 73(3):542-543. PMID: 33029931
Identification of Acute Giant Cell Arteritis in Real-World Data Using Administrative Claims-Based Algorithms.
Lee H, Tedeschi SK, Chen SK, Monach PA, Kim E, Liu J, Pethoe-Schramm A, Yau V, Kim SC.
ACR Open Rheumatol. 2021 Feb. 3(2):72-78. PMID: 33491920
Comparative Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults.
Patorno E, Pawar A, Bessette LG, Kim DH, Dave C, Glynn RJ, Munshi MN, Schneeweiss S, Wexler DJ, Kim SC.
Diabetes Care. 2021 Mar. 44(3):826-835. PMID: 33495295
Prevalence, incidence and cause-specific mortality of rheumatoid arthritis-associated interstitial lung disease among older rheumatoid arthritis patients.
Sparks JA, Jin Y, Cho SK, Vine S, Desai R, Doyle TJ, Kim SC.
Rheumatology (Oxford). 2021 Jan 18. PMID: 33462611
Development of a Medicare Claims-Based Model to Predict Persistent High-Dose Opioid Use After Total Knee Replacement.
Gopalakrishnan C, Desai RJ, Franklin JM, Jin Y, Lii J, Solomon DH, Katz JN, Lee YC, Franklin PD, Kim SC.
Arthritis Care Res (Hoboken). 2021 Jan 15. PMID: 33450136
The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy.
Solomon DH, Xu C, Collins J, Kim SC, Losina E, Yau V, Johansson FD.
Arthritis Res Ther. 2021 01 14. 23(1):26. PMID: 33446261
Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease.
Kirchgesner J, Desai RJ, Beaugerie L, Schneeweiss S, Kim SC.
Clin Gastroenterol Hepatol. 2020 Dec 30. PMID: 33387667